These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 806426)

  • 1. Parafon Forte tablets: a review of the literature.
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):123-6. PubMed ID: 806426
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind evaluation of Parafon Forte in the treatment of musculo-skeletal back conditions.
    Vernon WG
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):801-6. PubMed ID: 4629819
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of an acetaminophen-chlorzoxazone combination (parafon forte) in the treatment of acute musculoskeletal disorders.
    Walker JM
    Curr Ther Res Clin Exp; 1973 May; 15(5):248-52. PubMed ID: 4196784
    [No Abstract]   [Full Text] [Related]  

  • 4. Parafon Forte versus Robaxisal in skeletal muscle disorders: a double-blind study.
    Gready DM
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):666-73. PubMed ID: 825352
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a combined muscle relaxant-analgesic as an effective therapy for painful skeletal muscle spasm.
    Scheiner JJ
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):168-77. PubMed ID: 4623596
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of Parafon Forte tablets and soma compound in the treatment of painful skeletal muscle conditions.
    Miller AR
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):444-50. PubMed ID: 816602
    [No Abstract]   [Full Text] [Related]  

  • 7. Two chlorzoxazone (Parafon forte) overdoses and coma in one patient: reversal with flumazenil.
    Roberge RJ; Atchley B; Ryan K; Krenzelok EP
    Am J Emerg Med; 1998 Jul; 16(4):393-5. PubMed ID: 9672460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases.
    Powers BJ; Cattau EL; Zimmerman HJ
    Arch Intern Med; 1986 Jun; 146(6):1183-6. PubMed ID: 3521519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of orphenadrine/paracetamol combination tablets (Norgesic) on myalgia. A double-blind comparative study using a placebo in general practice].
    Høivik HO; Moe N; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Feb; 103(6):597-9. PubMed ID: 6346583
    [No Abstract]   [Full Text] [Related]  

  • 10. Electromyographic tests for the evaluation of effects of myotonolytic drugs in muscular reflexogenic hyperreflexive states.
    Bonne A; Heymans W; Rosselle N
    Electromyography; 1970; 10(3):219-25. PubMed ID: 5509968
    [No Abstract]   [Full Text] [Related]  

  • 11. Centrally acting oral skeletal muscle relaxants.
    Elenbaas JK
    Am J Hosp Pharm; 1980 Oct; 37(10):1313-23. PubMed ID: 6999895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of chlorzoxazone and paracetamol in co-chlorzoxazone tablet by multi-wavelength linear regression method].
    Ding L; Yang C; Zhan W; Wu H; Zheng K
    Guang Pu Xue Yu Guang Pu Fen Xi; 2000 Jun; 20(3):423-4. PubMed ID: 12958978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the analgesic muscle relaxants chlorzoxazone and diazepam in human plasma by reversed-phase liquid chromatography.
    Gaitonde CD; Pathak PV
    J Chromatogr; 1990 Jun; 528(2):407-14. PubMed ID: 2384578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle relaxants: chlorzoxazone compared with diazepam (a double-blind study).
    Scheiner JJ
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):51-7. PubMed ID: 812665
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of central muscle relaxants on single-dose pharmacokinetics of peroral paracetamol in man.
    Saano V; Elo HA; Paronen P
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):39-45. PubMed ID: 2303311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild analgesics in dentistry: a review.
    Malick AH
    Gen Dent; 1985; 33(2):123-7. PubMed ID: 3888774
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds.
    Cao Y; Dreixler JC; Roizen JD; Roberts MT; Houamed KM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):683-9. PubMed ID: 11181893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorzoxazone inhibits contraction of rat thoracic aorta.
    Dong DL; Luan Y; Feng TM; Fan CL; Yue P; Sun ZJ; Gu RM; Yang BF
    Eur J Pharmacol; 2006 Sep; 545(2-3):161-6. PubMed ID: 16859676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and tolerance of a combined oral rhinologic agent].
    Sachsenröder L; Renovanz HD; Flach D
    Arzneimittelforschung; 1972 Feb; 22(2):392-8. PubMed ID: 4112692
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorometric determination of chlorzoxazone in tablets and biological fluids.
    Stewart JT; Chan CW
    J Pharm Sci; 1979 Jul; 68(7):910-2. PubMed ID: 458615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.